National Cancer Institute; Amended Notice of Meeting, 3641-3642 [2011-1151]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 13 / Thursday, January 20, 2011 / Notices
Dated: January 13, 2011
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1135 Filed 1–19–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Program Project in Cardiovascular Diseases.
Date: February 8, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
Contact Person: Shelley S Sehnert, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7206, Bethesda, MD 20892–7924. 301–435–
0303. ssehnert@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Clinical Investigator and Research Scientist
Career Development Awards.
Date: February 9–10, 2011.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Stephanie J Webb, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7196,
Bethesda, MD 20892. 301–435–0291.
stephanie.webb@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Program Project in Cardiovascular Diseases.
Date: February 9, 2011
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
18:24 Jan 19, 2011
Jkt 223001
3641
Place: Sheraton Columbia Hotel, 10207
Wincopin Circle, Columbia, MD 21044.
Contact Person: Shelley S Sehnert, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7206, Bethesda, MD 20892–7924. 301–435–
0303. ssehnert@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Career Development Grants Review Panel.
Date: February 10–11, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal Gateway Marriott, 1700
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Keith A. Mintzer, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7186,
Bethesda, MD 20892–7924. 301–435–0280.
mintzerk@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Novel Technologies for Powering Ventricular
Assist Devices.
Date: February 11, 2011.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
Contact Person: Youngsuk Oh, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7182, Bethesda, MD 20892–7924. 301–435–
0277. yoh@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Pathway to Independence Awards.
Date: February 24–25, 2011.
Time: 8 a.m. to 3 p.m
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Crystal City, 2799
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Holly K. Krull, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7188,
Bethesda, MD 20892–7924. 301–435–0280.
krullh@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: January 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Cancer Institute; Amended
Notice of Meeting
[FR Doc. 2011–1146 Filed 1–19–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Methylation Meeting.
Date: March 8, 2011.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 8103, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Timothy C. Meeker, M.D.,
PhD, Scientific Review Officer, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8103, Bethesda, MD 20892, (301) 594–1279,
meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1149 Filed 1–19–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
February 17, 2011, 1 p.m. to February
E:\FR\FM\20JAN1.SGM
20JAN1
3642
Federal Register / Vol. 76, No. 13 / Thursday, January 20, 2011 / Notices
17, 2011, 3 p.m., Legacy Hotel and
Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852 which was
published in the Federal Register on
January 5, 2011, 76 FR 577.
This notice is amending the start time
of the meeting from 1 p.m. to 8:30 a.m.
The meeting is closed to the public.
Dated: January 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1151 Filed 1–19–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Innovative
and Early Stage Development of Emerging
Technologies in Biospecimen Science.
Date: February 24, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Donald L. Coppock, PhD,
Scientific Review Officer, Scientific Review
and Logistic Branch, Division of Extramural
Activities, NCI, National Institutes of Health,
6116 Executive Blvd., Rm 7151, Bethesda,
MD 20892. 301–451–9385.
coppockdl@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Radioprotector/Mitigator Development for
Radiotherapy.
Date: February 24–25, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
VerDate Mar<15>2010
18:24 Jan 19, 2011
Jkt 223001
Contact Person: Viatcheslav A.
Soldatenkov, M.D., PhD, Scientific Review
Officer, Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, 6116 Executive Blvd Room
8057, Bethesda, MD 20892–8329. 301–451–
4758. soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Creating
Interdisciplinary Research Teams in Basic
Behavioral and Social Science Research.
Date: March 7, 2011.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Ellen K Schwartz, EDD,
MBA, Scientific Review Officer, Special
Review & Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8055B, Bethesda, MD 20892–8329.
301–594–1215. schwarel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancerrelated Applications for Conferences and
Scientific Meetings.
Date: March 7, 2011.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Ellen K Schwartz, EDD,
MBA, Scientific Review Officer, Special
Review & Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8055B, Bethesda, MD 20892–8329.
301–594–1215. schwarel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Novel
Imaging Agents to Expand the Clinical
Toolkit for Cancer Diagnosis, Staging and
Treatment.
Date: March 8, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: The Legacy Hotel, 1775 Rockville
Pike, Rockville, MD 20852.
Contact Person: Savvas C Makrides, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm 8050a, Bethesda,
MD 20892. 301–496–7421.
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Prevention Research Small Grant Program
(R03).
Date: March 10–11, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance M Street Hotel. 1143
New Hampshire Avenue, NW., Washington,
DC 20037.
Contact Person: Irina Gordienko, PhD,
Scientific Review Officer, Scientific Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm. 7073, Bethesda,
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
MD 20892. 301–594–1566.
gordienkoiv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Emerging
Technologies for Cancer Research.
Date: March 29–30, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Viatcheslav A.
Soldatenkov, M.D., PhD, Scientific Review
Officer, Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, 6116 Executive Blvd Room
8057, Bethesda, MD 20892–8329. 301–451–
4758. soldatenkovv@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1150 Filed 1–19–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, KOMP (KNOCK-OUT MOUSE
PROJECT).
Date: February 16, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal Gateway Marriott, 1700
Jefferson Davis Highway, Arlington, VA
22202.
E:\FR\FM\20JAN1.SGM
20JAN1
]]>Agencies
[Federal Register Volume 76, Number 13 (Thursday, January 20, 2011)]
[Notices]
[Pages 3641-3642]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1151]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, February 17, 2011, 1 p.m. to
February
[[Page 3642]]
17, 2011, 3 p.m., Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852 which was published in the Federal Register on
January 5, 2011, 76 FR 577.
This notice is amending the start time of the meeting from 1 p.m.
to 8:30 a.m. The meeting is closed to the public.
Dated: January 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-1151 Filed 1-19-11; 8:45 am]
BILLING CODE 4140-01-P
